• Cardiology
    Lipid (ASCVD)

Cardiovascular diseases, including ischaemic heart diseases and stroke, are the leading causes of death worldwide and in Malaysia.1,2 The world’s biggest killer is ischaemic heart disease, responsible for 16% of the world’s total deaths, amounting to 8.9 million deaths in 2019.1


4 in 10 Malaysian adults (8 million people) have raised total cholesterol level, and 1 in 3 Malaysians have uncontrolled cholesterol levels despite on medications.2


Low-density lipoprotein cholesterol (LDL-C) has been identified as a modifiable risk that is causally associated with atherosclerotic cardiovascular disease (ASCVD) risk.3 ASCVD events can be reduced by 22% with each 1 mmol/L reduction of LDL-C.4


Read more on the latest clinical evidence about lipid management below.

For more information, click on read more.


1.World Health Organization (WHO). The top 10 causes of death. Updated 9 December 2020. Accessed from https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
2.Institute for Public Health Malaysia 2020. National Health and Morbidity Survey (NHMS) 2019:  Non-communicable diseases, healthcare demand and health literacy- Key findings.
3.Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111-88.
4. Grundy SM, et al. Guidelines for the management of high blood cholesterol. [Updated 2019 Nov 30]. In: Feingold KR, et al., editors. Endotext [Internet]. South Dartmouth (MA) 2000.


Ask Speakers


Medical Information Request